Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M
- Written by PR Newswire Asia - Asian Spectator
![]() |
MELBOURNE, Australia, Oct. 17, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today provides an update on its revenue and operational performance for the quarter ended 30 September 2024 (Q3 2024).
Revenue update, full year guidance reaffirmed
- Unaudited total revenue of approximately US$135 million (AU$201...